Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Williamson

Showing results (931-940 of 1,028) with videos related to

Pageof 103
Sort By:
Scientific Reports|August 19, 2024
Sound-seeking before and after hearing loss in miceJessica Mai, Rowan Gargiullo, Megan Zheng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2013
Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes studyJoanne R Morling, Jonathan A Fallowfield, Rachel M Williamson, et al.
JAMA|September 3, 2019
Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection FractionJames L Januzzi, Margaret F Prescott, Javed Butler, et al.
The American Journal of Tropical Medicine and Hygiene|July 11, 2018
Relative Contribution of Schistosomiasis and Malaria to Anemia in Western KenyaEmily M Valice, Ryan E Wiegand, Pauline N M Mwinzi, et al.
Diabetes Care|April 12, 2011
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyRachel M Williamson, Jackie F Price, Stephen Glancy, et al.
Circulation. Heart Failure|May 17, 2021
Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection FractionSean P Murphy, Margaret F Prescott, Alan S Maisel, et al.
JACC. Heart Failure|November 15, 2020
Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection FractionIleana L Piña, Alexander Camacho, Nasrien E Ibrahim, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
Exploration of Germline Correlates and Risk of Immune-Related Adverse Events in Advanced Cancer Patients Treated with Immune Checkpoint InhibitorsEmma Titmuss, Irene S Yu, Erin D Pleasance, et al.
Cell Death & Disease|February 7, 2025
Genetically edited human placental organoids cast new light on the role of ACE2Anya L Arthurs, Bianca Dietrich, Martin Knöfler, et al.
Lancet (London, England)|January 29, 2013
The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trialJo Howard, Moira Malfroy, Charlotte Llewelyn, et al.
Pageof 103

Showing results (931-940 of 1,028) with videos related to

Sort By:
Pageof 103
Scientific Reports|August 19, 2024
Sound-seeking before and after hearing loss in miceJessica Mai, Rowan Gargiullo, Megan Zheng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 19, 2013
Non-invasive hepatic biomarkers (ELF and CK18) in people with type 2 diabetes: the Edinburgh type 2 diabetes studyJoanne R Morling, Jonathan A Fallowfield, Rachel M Williamson, et al.
JAMA|September 3, 2019
Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection FractionJames L Januzzi, Margaret F Prescott, Javed Butler, et al.
The American Journal of Tropical Medicine and Hygiene|July 11, 2018
Relative Contribution of Schistosomiasis and Malaria to Anemia in Western KenyaEmily M Valice, Ryan E Wiegand, Pauline N M Mwinzi, et al.
Diabetes Care|April 12, 2011
Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes StudyRachel M Williamson, Jackie F Price, Stephen Glancy, et al.
Circulation. Heart Failure|May 17, 2021
Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection FractionSean P Murphy, Margaret F Prescott, Alan S Maisel, et al.
JACC. Heart Failure|November 15, 2020
Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection FractionIleana L Piña, Alexander Camacho, Nasrien E Ibrahim, et al.
Current Oncology (Toronto, Ont.)|April 26, 2024
Exploration of Germline Correlates and Risk of Immune-Related Adverse Events in Advanced Cancer Patients Treated with Immune Checkpoint InhibitorsEmma Titmuss, Irene S Yu, Erin D Pleasance, et al.
Cell Death & Disease|February 7, 2025
Genetically edited human placental organoids cast new light on the role of ACE2Anya L Arthurs, Bianca Dietrich, Martin Knöfler, et al.
Lancet (London, England)|January 29, 2013
The Transfusion Alternatives Preoperatively in Sickle Cell Disease (TAPS) study: a randomised, controlled, multicentre clinical trialJo Howard, Moira Malfroy, Charlotte Llewelyn, et al.
Pageof 103